Relationship between rosacea and chronic obstructive pulmonary disease: Rosacea and comorbidities

Causal relationship and potential pathogenic mechanisms between rosacea with pharyngeal and laryngeal cancer

OBJECTIVE

Rosacea is a common chronic inflammatory skin disease. Observational studies reported the association between rosacea and cancer. The causal relationship between rosacea and cancer has been reported rarely.

METHODS

We employed a two-sample Mendelian Randomization (MR) study to assess the causality between rosacea and 17 subtypes of cancers. Rosacea and cancers' association Genome-Wide Association Study (GWAS) data were collected. The Inverse Variance Weighted (IVW) method was utilized as the principal method in our Mendelian Randomization (MR) study, with additional using the MR-Egger, weighted median, simple mode, and weighted mode methods. The MR-Egger intercept test, Cochran's Q test, MR-Pleiotropy RESidual Sum and Outlier (MR-PRESSO) and leave-one-out analysis were conducted to identify heterogeneity and pleiotropy. After that, Disease-related genes were also referenced from GeneCard.

RESULTS

After our MR analysis, we found rosacea has a causal relationship with pharyngeal and laryngeal cancer (PLC, Odds Ratio [OR = 1.137], 95% CI 1.010‒1.283, p-value = 0.035). Rosacea may increase the risk of PLC. No causal link between rosacea and other cancer was observed. No heterogeneity or pleiotropy was observed. Reversed MR showed PLC has no causal effect on rosacea. Furthermore, disease-related genes were obtained. The intersecting genes between rosacea and PLC were identified. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed, these intersecting genes were associated with pathways related to immunity inflammation procedures or pathways.

CONCLUSION

This study provided new evidence of the relationship between rosacea and PLC. Rosacea may play a facilitative role in PLC progression. Identification of related genes related to rosacea and PLC offers new scene for investigating the potential pathogenesis of PLC, this could provide innovative and efficient ways to address PLC treatment.

LEVEL OF EVIDENCE

Level II. Mendelian Randomized (MR) studies are second only to randomized controlled trials in terms of the level of evidence.

Evaluation of atherosclerotic risk in rosacea patients through serum fetuin-A and carotid intima media thickness

BACKGROUND

The link between rosacea and various systemic conditions has been growing in prominence, even though the relationship between rosacea and cardiovascular disease remains a subject of debate in current research.

AIMS

Detecting the connection between rosacea and subclinical atherosclerosis using laboratory and ultrasonographic parameters.

METHODS

Fifty rosacea patients and 49 control were included in the study. Demographic, clinical, and laboratory data, including serum high sensitivity C-reactive protein (hs-CRP), fetuin-A (FA), and matrix gla protein levels were assessed. Carotid intima-media thickness (CIMT) was measured by carotid ultrasonography.

RESULTS

Serum hs-CRP levels (p = 0.009) and mean CIMT (p = 0.001) were significantly higher, while serum FA levels were significantly lower (p < 0.001) in the rosacea patients compared with control. The number of patients with mean CIMT>75th percentile according to age and sex were significantly higher in the rosacea group (p = 0.001). Rosacea patients with ocular involvement exhibited significantly higher hs-CRP values in comparison to those without ocular involvement (p = 0.008). No significant correlation was detected between disease duration, severity, subtype and the study parameters.

CONCLUSIONS

This study results suggest that rosacea poses an independent risk for subclinical atherosclerosis regardless of its severity, duration, or subtype. Therefore, individuals diagnosed with rosacea should receive careful evaluation and monitoring to detect possible cardiovascular complications promptly. Furthermore, our study hints at a potential elevated risk of subclinical inflammation in rosacea patients with ocular involvement, warranting additional attention and further investigation.

Assessment of Frequency of Rosacea Subtypes in Patients With Rosacea: A Systematic Review and Meta-analysis

Importance

Four distinct rosacea subtypes have traditionally been recognized, but the frequency of these subtypes among patients with rosacea remains unknown.

Objective

To assess the frequency of 4 rosacea subtypes.

Data Sources

This systemic review and meta-analysis included a search of 2 databases, PubMed and Embase, from inception of the databases to November 2, 2021. The search was filtered to include only studies of human participants published in English, French, and German.

Study Selection

Studies were screened independently by 2 of the authors and were included if they were original with a sample size of 25 or more patients and reported absolute numbers or frequency of patients affected by rosacea subtypes. Studies that did not report sufficient data to calculate the proportions of subtypes were excluded.

Data Extraction and Synthesis

Data extraction was performed independently and in duplicate by 2 of the authors, using the search term rosacea, according to the Preferred Reporting items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The search term, objectives, and study protocol methods were defined before the study was initiated. A total of 292 studies were included for full-text assessment. Owing to the heterogeneity of the included studies, a random-effects model was used.

Main Outcome and Measures

The main outcome was the proportion of patients with rosacea in each of the 4 major subtype groups defined by the 2002 National Rosacea Society classification system. Measures were absolute numbers or frequency of patients affected by each of the 4 rosacea subtypes.

Results

A total of 39 studies examining 9190 patients with rosacea were included. The pooled proportion of erythematotelangiectatic rosacea was 56.7% (95% CI, 51.4%-62.0%), of papulopustular rosacea was 43.2% (95% CI, 38.8%-47.6%), of phymatous rosacea was 7.4% (95% CI, 6.1%-8.9%), and of ocular rosacea was 11.1% (95% CI, 6.7%-16.3%). Subtype distribution occurred equally among men and women except for phymatous rosacea, which was more prevalent in men. Studies from Africa showed the lowest proportion of erythematotelangiectatic rosacea. Differences in frequency of subtypes were observed when stratification by publication year was performed.

Conclusion and Relevance

In this systematic review and meta-analysis, differences were found in rosacea subtypes by patient sex and by continent of origin and publication year of included studies. Erythematotelangiectatic and papulopustular rosacea were the most prevalent subtypes, but data should be interpreted with caution. Future studies should use the phenotype-based rosacea approach.